Glaucia Vilar-Pereira Selected Research

Sinus Arrhythmia

1/2019	TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease.
10/2016	Resveratrol Reverses Functional Chagas Heart Disease in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Glaucia Vilar-Pereira Research Topics

Disease

8	Heart Diseases (Heart Disease) 01/2021 - 01/2014
8	Infections 01/2021 - 10/2012
6	Cardiomyopathies (Cardiomyopathy) 10/2016 - 06/2014
3	Chagas Disease (American Trypanosomiasis) 01/2021 - 11/2014
3	Heart Injuries 01/2020 - 01/2015
2	Sinus Arrhythmia 01/2019 - 10/2016
2	Fibrosis (Cirrhosis) 01/2019 - 01/2016
2	Myocarditis (Carditis) 10/2016 - 01/2016
1	Memory Disorders (Memory Loss) 01/2021
1	Chagas Cardiomyopathy 01/2021
1	Persistent Infection 01/2020
1	Bradycardia 01/2020
1	Weight Loss (Weight Reduction) 12/2015
1	Hypertrophy 03/2015
1	Autonomic Nervous System Diseases (Dysautonomia) 11/2014
1	Cardiac Arrhythmias (Arrythmia) 11/2014
1	Necrosis 06/2014
1	Atrioventricular Block 01/2014
1	Meningoencephalitis 10/2012

Drug/Important Bio-Agent (IBA)

4	benzonidazole (benznidazole)IBA 01/2021 - 01/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 10/2012
2	Pharmaceutical PreparationsIBA 01/2021 - 10/2016
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2014
2	Connexin 43 (Connexin43)IBA 01/2019 - 03/2015
2	Pentoxifylline (Trental)FDA LinkGeneric 01/2016 - 03/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 06/2014
2	Fibronectins (Fibronectin)IBA 03/2015 - 01/2014
1	CytokinesIBA 01/2021
1	Chemotactic FactorsIBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	CC ChemokinesIBA 01/2020
1	Met- RANTESIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	CCR1 ReceptorsIBA 01/2020
1	4- (4- (3- (pyridin- 2- yl)- 1H- pyrazol- 4- yl)pyridin- 2- yl)- N- (tetrahydro- 2H- pyran- 4- yl)benzamideIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 10/2016
1	AntioxidantsIBA 10/2016
1	ResveratrolIBA 10/2016
1	tempolIBA 10/2016
1	SandIBA 12/2015
1	VaccinesIBA 01/2015
1	Cholinergic ReceptorsIBA 11/2014
1	AntibodiesIBA 11/2014
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2014
1	Cholinergic Agents (Cholinergics)IBA 11/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2014
1	Infliximab (Remicade)FDA Link 01/2014
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2012
1	Antiparasitic Agents (Antiparasitics)IBA 10/2012

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2015
1	Investigational Therapies (Experimental Therapy) 10/2016
1	Combination Drug Therapy (Combination Chemotherapy) 01/2016